Amplified response of drug-induced liver fibrosis via immune cell co-culture in a 3D in vitro hepatic fibrosis model
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
immune cell activation associated ECM deposition. In this study, the developed triple co-culture model has the potential to elucidate cell progression roles in liver fibrosis and can be applied in drug screening and toxicity assessments targeting liver fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
Abe, R., Donnelly, S. C., Peng, T., Bucala, R., & Metz, C. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7556 · Cited by 967
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury
Jaeschke, H., & Lemasters, J. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01209-5 · Cited by 589
Schwende, H., Fitzke, E., Ambs, P., & Dieter, P. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.4.555 · Cited by 581
Role of Kupffer cells in the pathogenesis of liver disease
Kolios, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i46.7413 · Cited by 505
Research works printed but not linked: 8
- Tsuchida, 2017, Nat. Rev. Gastroenterol. Hepatol., 14, 397, 10.1038/nrgastro.2017.38 · DOI · Paper page
- Lee, 2019, Adv. Funct. Mater., 29, 1900075, 10.1002/adfm.201900075 · DOI · Paper page
- Cuvellier, 2021, Biomaterials, 269, 120611, 10.1016/j.biomaterials.2020.120611 · DOI · Paper page
- Iredale, 1996, Hepatology, 24, 176
- Xu, 2018, Int. J. Mol. Med., 42, 3602
- Bichenapally, 2022, Cureus, 14, e30910
- Olsen, 2011, Am. J. Physiol.: Gastrointest. Liver Physiol., 301, G110
- Zahmatkesh, 2022, Arch. Toxicol., 96, 1799, 10.1007/s00204-022-03265-7 · DOI
Cited by
Human liver immunology: from in vitro models to new insights
Rezvani, M. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01312-8 · Cited by 23
Challenges of in vitro modelling of liver fibrosis
Ros-Tárraga, P., Villanueva-Bádenas, E., Sanchez-Gonzalez, E., Ferrer, G. G., Donato, M. T., & Tolosa, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1567916 · Cited by 13
Bio-fabrication of fibrotic liver microtissues as a scalable and drug-responsive in vitro model
Majidi, F., Choshali, M. A., Izadi, A., Hajari, M. A., Saheli, M., Ziai, S. A., Vosough, M., & Piryaei, A. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126242 · Cited by 5
Ouyang, R., Li, X., Hao, J., Lin, J., Lan, H. Y., Peng, J., Li, X., Tian, Z., & Sun, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1708240 · Cited by 5
Qiu, X., Wang, X., Yuan, X., Yao, M., Sun, Z., Gao, Z., Zhang, J., Xia, C., Zhang, P., Sun, L., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108010 · Cited by 1
Wang, Z., Shu, Y.-R., Luo, Y., Xi, D., Ren, T., Yuan, L., & Fan, X.-P. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03044 · Cited by 5
Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model
Taheri, P., Majidi, F., Nouri, K., Nouri, M., Zarrabi, M., Rismani, E., Piryaei, A., & Vosough, M. (2026) · In vitro models · doi:10.1007/s44164-026-00142-w
Lee, S., Kim, D., Seok, H., & Moon, Y. (2026) · RSC Advances · doi:10.1039/d6ra05249e
Metadata
- Authors
- Jung, H., Kyun, M.-L., Kwon, J.-I., Kim, J., Kim, J.-K., Park, D., Lee, Y. B., & Moon, K.-S.
- Affiliations
- Korea Institute of Toxicology (KR)
- Hannam University (KR)
- Corresponding author
- Park, Daeui
- Lee, Yu Bin
- Moon, Kyoung-Sik
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2024
- Volume
- 12
- Issue
- 24
- Pages
- 6351-6367
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- OpenAlex
- W4403821714
- Cited by
- 10
- References
- 60
- Citations by year
- 2026: 3 · 2025: 7
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Korea Institute of Toxicology (2710008773)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- liver fibrosis, 3D in vitro model, extracellular matrix deposition, immune cell activation, drug screening, toxicity prediction
- MeSH terms
- Cell Line, Extracellular Matrix, Humans, Liver Cirrhosis, Macrophages, Methotrexate, Coculture Techniques, Hepatocytes, Transforming Growth Factor beta1, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.